463 related articles for article (PubMed ID: 26794710)
21. The immunomodulatory function of mesenchymal stem cells: mode of action and pathways.
Uccelli A; de Rosbo NK
Ann N Y Acad Sci; 2015 Sep; 1351():114-26. PubMed ID: 26152292
[TBL] [Abstract][Full Text] [Related]
22. Immunological aspects of allogeneic mesenchymal stem cell therapies.
Griffin MD; Ritter T; Mahon BP
Hum Gene Ther; 2010 Dec; 21(12):1641-55. PubMed ID: 20718666
[TBL] [Abstract][Full Text] [Related]
23. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
[TBL] [Abstract][Full Text] [Related]
24. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis.
Lim JY; Im KI; Lee ES; Kim N; Nam YS; Jeon YW; Cho SG
Sci Rep; 2016 Jun; 6():26851. PubMed ID: 27246365
[TBL] [Abstract][Full Text] [Related]
25. Potential therapeutic applications of mesenchymal stromal cells.
Larsen S; Lewis ID
Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
[TBL] [Abstract][Full Text] [Related]
26. Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system.
Rahimzadeh A; Mirakabad FS; Movassaghpour A; Shamsasenjan K; Kariminekoo S; Talebi M; Shekari A; Zeighamian V; Ghalhar MG; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016; 44(2):559-70. PubMed ID: 25340260
[TBL] [Abstract][Full Text] [Related]
27. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance.
Franquesa M; Hoogduijn MJ; Baan CC
Curr Opin Organ Transplant; 2012 Aug; 17(4):355-61. PubMed ID: 22710385
[TBL] [Abstract][Full Text] [Related]
28. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.
Yan Z; Zhuansun Y; Chen R; Li J; Ran P
Exp Cell Res; 2014 May; 324(1):65-74. PubMed ID: 24681107
[TBL] [Abstract][Full Text] [Related]
30. Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications.
Kim N; Cho SG
Int J Hematol; 2016 Feb; 103(2):129-37. PubMed ID: 26662288
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye.
Ko JH; Lee HJ; Jeong HJ; Kim MK; Wee WR; Yoon SO; Choi H; Prockop DJ; Oh JY
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):158-63. PubMed ID: 26699483
[TBL] [Abstract][Full Text] [Related]
32. Effects of hypoxia on the immunomodulatory properties of human gingiva-derived mesenchymal stem cells.
Jiang CM; Liu J; Zhao JY; Xiao L; An S; Gou YC; Quan HX; Cheng Q; Zhang YL; He W; Wang YT; Yu WJ; Huang YF; Yi YT; Chen Y; Wang J
J Dent Res; 2015 Jan; 94(1):69-77. PubMed ID: 25403565
[TBL] [Abstract][Full Text] [Related]
33. Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects.
Fontaine MJ; Shih H; Schäfer R; Pittenger MF
Transfus Med Rev; 2016 Jan; 30(1):37-43. PubMed ID: 26689863
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants.
Hoornaert CJ; Luyckx E; Reekmans K; Dhainaut M; Guglielmetti C; Le Blon D; Dooley D; Fransen E; Daans J; Verbeeck L; Quarta A; De Vocht N; Lemmens E; Goossens H; Van der Linden A; Roobrouck VD; Verfaillie C; Hendrix S; Moser M; Berneman ZN; Ponsaerts P
Stem Cells; 2016 Jul; 34(7):1971-84. PubMed ID: 26992046
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells and immunomodulation: current status and future prospects.
Gao F; Chiu SM; Motan DA; Zhang Z; Chen L; Ji HL; Tse HF; Fu QL; Lian Q
Cell Death Dis; 2016 Jan; 7(1):e2062. PubMed ID: 26794657
[TBL] [Abstract][Full Text] [Related]
36. [Bone and Stem Cells. Isolation and immunomodulation of mesenchymal stem cells].
Matsuzaki Y; Sato Y
Clin Calcium; 2014 Apr; 24(4):575-83. PubMed ID: 24681504
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
39. [Mesenchymal stem cells and their immunological properties].
Lisianyĭ MI
Fiziol Zh (1994); 2013; 59(3):126-34. PubMed ID: 23957174
[TBL] [Abstract][Full Text] [Related]
40. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
